Study suggests PD-1 inhibitors against aggressive pediatric brain cancer subtype

A University of Colorado Cancer Center study published in the journal Pediatric Blood Cancers lays the scientific groundwork for the use of PD-1 inhibitors with an aggressive form of brain cancer, namely supratentorial pediatric ependymoma.

Read more: https://www.eurekalert.org/pub_releases/2018-01/uoca-ssp012918.php